Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Respiratory Infections specialty page provides respiratory infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


RSV Vaccine Candidate DS-Cav1 Shows Early Promise in Phase 1 Trial
Investigators say that 12 weeks following vaccination neutralizing antibodies remained 5- to 10-fold above baseline levels in all vaccine dosage groups.
Two-Thirds of Pneumonia Patients Receive Excessive Antibiotics
The study found that two-thirds of patients receive excess antibiotic treatment and that every excess day increased a patient's risk of adverse events by 5%.
Reports of Expired Flu Vaccine Administration Comes as 2018-19 Doses Set to Expire
As injectable influenza vaccine doses from the 2018-19 season are set to expire on June 30, 2019, CDC investigators detail 192 cases of expired vaccine administration over the last year.
What Is the Link Between RSV and Homelessness?
RSV is a pernicious pathogen that may spread easily among the homeless and possibly cause more severe disease.
Effectiveness of Pertussis Vaccine May Wane Over Time, Study Shows
Kaiser Permanente Northern California’s study shows that the pertussis vaccine weakens as time passes after a patient's most recent vaccination.
Sourcing the 1918 Spanish Influenza Pandemic With a Walk Down Viral Memory Lane
What happens when you get a virologist and a military historian together? New insight into an old pandemic.
Not All Clinicians Adhere to Pediatric Pneumonia Guidelines, Study Finds
Antibiotics and chest x-rays are routinely used to diagnose and treat pediatric CAP, despite guidelines advising the contrary. 
Ohio Hospital Searches for Source of Deadly Legionnaires' Outbreak
At least 8 cases of Legionnaires’ disease have been confirmed in an outbreak within an Ohio hospital that just opened on April 28, 2019
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?